Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?

Background: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease hallmarked by irreversible damage of cartilage and bone. Matrix metalloproteinases (MMPs) involved in connective tissue remodeling play an important role in this process. Numerous MMPs have been examined in humans and animals, but their functions are still not fully understood. Therefore, we investigated the role of MMPs in the K/BxN serum-transfer model of RA with the broad-spectrum MMP inhibitor subantimicrobial dose doxycycline (SDD) using complex in vivo and in vitro methodolgy. Methods: Chronic arthritis was induced by repetitive i.p. injections of K/BxN serum in C57BL/6J mice. SDD was administered daily in acidified drinking water (0.5 mg/mL, 80 mg/kg) during the 30 days experimental period. Mechanonociceptive threshold of the paw was evaluated by aesthesiometry, grasping ability by grid test, arthritis severity by scoring, neutrophil myeloperoxidase activity by luminescence, vascular hyperpermeability and MMP activity by fluorescence in vivo imaging and the latter also by gelatin zymography, bone structure by micro-computed tomography (micro-CT). Plasma concentrations of doxycycline were determined by liquid chromatography-mass spectrometry analysis. Results: K/BxN serum induced significant inflammatory signs, mechanical hyperalgesia, joint function impairment, increased myeloperoxidase activity and vascular hyperpermeability. Significant increase of MMP activity was also observed both in vivo and ex vivo with elevation of the 57–60, 75, and 92 kDa gelatinolytic isoforms in the arthritic ankle joints, but neither MMP activity nor any above described functional parameters were influenced by SDD. Most importantly, SDD significantly reduced bone mineral density in the distal tibia and enhanced the Euler number in the ankle. Arthritis-induced microarchitectural alterations demonstrating increased irregularity and cancellous bone remodeling, such as increased Euler number was significantly elevated by SDD in both regions. Conclusion: We showed increase of various MMP activities in the joints by in vivo fluorescence imaging together with ex vivo zymography, and investigated their functional significance using the broad-spectrum MMP inhibitor SDD in the translational RA model. This is the first demonstration that SDD worsens arthritis-induced bone microarchitectural alterations, but it appears to be independent of MMP inhibition.

[1]  D. Kosson,et al.  Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism , 2018, Drug design, development and therapy.

[2]  G. Fields,et al.  Matrix metalloproteinase collagenolysis in health and disease. , 2017, Biochimica et biophysica acta. Molecular cell research.

[3]  B. Fingleton Matrix metalloproteinases as regulators of inflammatory processes. , 2017, Biochimica et biophysica acta. Molecular cell research.

[4]  D. Walsh,et al.  Pain mechanisms in rheumatoid arthritis. , 2017, Clinical and experimental rheumatology.

[5]  G. Viana,et al.  Doxycycline induces bone repair and changes in Wnt signalling , 2017, International Journal of Oral Science.

[6]  P. Mátyus,et al.  Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse , 2017, Scientific Reports.

[7]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[8]  D. Kooyman,et al.  A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology , 2016, Disease markers.

[9]  M. Jougasaki,et al.  Matrix Metalloproteinases in Non-Neoplastic Disorders , 2016, International journal of molecular sciences.

[10]  L. Golub,et al.  Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. , 2016, International dental journal.

[11]  J. Szolcsányi,et al.  Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice , 2016, Arthritis Research & Therapy.

[12]  P. Ferdinandy,et al.  Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients , 2015, European journal of clinical investigation.

[13]  T. Kiss,et al.  Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis , 2015, Brain, Behavior, and Immunity.

[14]  J. Nyman,et al.  Effects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J mice , 2015, Bone reports.

[15]  A. Kuliopulos,et al.  Mouse Matrix Metalloprotease‐1a (Mmp1a) Gives New Insight Into MMP Function , 2014, Journal of cellular physiology.

[16]  V. Geoffroy,et al.  Dkk‐1–Mediated Inhibition of Wnt Signaling in Bone Ameliorates Osteoarthritis in Mice , 2014, Arthritis & rheumatology.

[17]  A. Dufour,et al.  Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritis. , 2014, Cell reports.

[18]  A. Mócsai,et al.  Differential Regulatory Role of Pituitary Adenylate Cyclase–Activating Polypeptide in the Serum-Transfer Arthritis Model , 2014, Arthritis & rheumatology.

[19]  S. Rankin,et al.  Antibiotic administration in the drinking water of mice. , 2014, Journal of the American Association for Laboratory Animal Science : JAALAS.

[20]  P. Ferdinandy,et al.  Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. , 2014, Pharmacological research.

[21]  P. Angel,et al.  Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis , 2013, Arthritis Research & Therapy.

[22]  A. Gibofsky,et al.  Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. , 2012, The American journal of managed care.

[23]  R. Greenwald The road forward: the scientific basis for tetracycline treatment of arthritic disorders. , 2011, Pharmacological research.

[24]  C. López-Otín,et al.  Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model , 2010, Arthritis research & therapy.

[25]  R. Kappelhoff,et al.  Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression. , 2010, Arthritis and rheumatism.

[26]  C. Svensson,et al.  Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis , 2010, PAIN®.

[27]  F. Cunha,et al.  IL-17 mediates articular hypernociception in antigen-induced arthritis in mice , 2010, PAIN.

[28]  D. Frommhold,et al.  Critical role of phospholipase Cγ2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis , 2009, The Journal of experimental medicine.

[29]  C. Libert,et al.  Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation , 2007, Journal of leukocyte biology.

[30]  P. Klimiuk,et al.  Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. , 2006, The Journal of rheumatology.

[31]  Michael C. Wendl,et al.  Argonaute—a database for gene regulation by mammalian microRNAs , 2005, BMC Bioinformatics.

[32]  Hajime Mishima,et al.  Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[33]  S. Grässel,et al.  Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. , 2004, Experimental cell research.

[34]  M. Pytlik,et al.  Effects of Doxycycline on Mechanical Properties of Bones in Rats with Ovariectomy-Induced Osteopenia , 2004, Calcified Tissue International.

[35]  M. Zabala,et al.  Rapid and simple determination of doxycycline in serum by high-performance liquid chromatography. Application to particulate drug delivery systems. , 2004, Journal of chromatography. A.

[36]  F. Breedveld,et al.  Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[37]  R. Toes,et al.  Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 , 2002, Annals of the rheumatic diseases.

[38]  Shigeyoshi Itohara,et al.  The Role of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Antibody-Induced Arthritis , 2002, The Journal of Immunology.

[39]  B. Baxter,et al.  Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. , 2002, Journal of vascular surgery.

[40]  J. Engler,et al.  Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. , 2000, Biochimica et biophysica acta.

[41]  Y. Okada,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis , 2000, Annals of the rheumatic diseases.

[42]  J. V. van Meurs,et al.  Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. , 1999, Arthritis and rheumatism.

[43]  P. Petrow,et al.  Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[44]  K. Brandt,et al.  Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. , 1999, Arthritis and rheumatism.

[45]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[46]  W. Giannobile,et al.  Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms , 1998, Advances in dental research.

[47]  P. Vadas,et al.  Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2. , 1998, The Journal of rheumatology.

[48]  S. Santavirta,et al.  Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. , 1997, Arthritis and rheumatism.

[49]  R. Heller,et al.  Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes* , 1996, The Journal of Biological Chemistry.

[50]  A. Koch,et al.  Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[51]  C. López-Otín,et al.  Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.

[52]  J. Pelletier,et al.  The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. , 1996, The Journal of clinical investigation.

[53]  D. Wernicke,et al.  Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. , 1996, The Journal of rheumatology.

[54]  K. Geoghegan,et al.  Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.

[55]  J. Delaissé,et al.  Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. , 1995, Journal of cell science.

[56]  C. López-Otín,et al.  Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. , 1994, The Journal of biological chemistry.

[57]  P. Vadas,et al.  Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. , 1992, Biochemical pharmacology.

[58]  L. Golub,et al.  Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. , 1992, The Journal of rheumatology.

[59]  A. Eisen,et al.  Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Laskin,et al.  Tetracyclines inhibit human synovial collagenase in vivo and in vitro. , 1987, The Journal of rheumatology.

[61]  Y. Okada,et al.  A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. , 1986, The Journal of biological chemistry.

[62]  Renay Gloria Lights and Shadows , 1897, The Journal of Comparative Medicine and Veterinary Archives.

[63]  Bálint Botz,et al.  Hydrophobic cyanine dye-doped micelles for optical in vivo imaging of plasma leakage and vascular disruption , 2015, Journal of biomedical optics.

[64]  Xun Li,et al.  An updated patent therapeutic agents targeting MMPs. , 2012, Recent patents on anti-cancer drug discovery.

[65]  C. Brinckerhoff,et al.  Matrix metalloproteinases: role in arthritis. , 2006, Frontiers in bioscience : a journal and virtual library.

[66]  T. Aigner,et al.  MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. , 2004, Clinical and experimental rheumatology.

[67]  Michael J. Green,et al.  Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. , 2003, Rheumatology.

[68]  J. Mudgett,et al.  Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. , 1998, Arthritis and rheumatism.